Back
Berkshire Hathaway Vs. Summit Therapeutics Industry Stock Comparison
Sell
45
BRK.A
Berkshire Hathaway
Last Price:
685,745.00
Seasonality Move:
5.52%
Buy
79
SMMT
Summit Therapeutics
Last Price:
24.55
Seasonality Move:
26.72%
Sell
45
Berkshire Hathaway (BRK.A)
is a Sell
Is Berkshire Hathaway a Buy, Sell or Hold?
- The current Berkshire Hathaway [BRK.A] share price is $685,250.00. The Score for BRK.A is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- BRK.A is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
79
Summit Therapeutics (SMMT)
is a Buy
Is Summit Therapeutics a Buy, Sell or Hold?
- The current Summit Therapeutics [SMMT] share price is $26.22. The Score for SMMT is 79, which is 58% above its historic median score of 50, and infers lower risk than normal.
- SMMT is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BRK.A Stock Price Chart
What is Berkshire Hathaway's stock price today?
-
The Berkshire Hathaway share price today is $685,250.00
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BRK.A is experiencing slight buying pressure.
SMMT Stock Price Chart
What is Summit Therapeutics's stock price today?
-
The Summit Therapeutics share price today is $26.22
The current trend is moderately bullish and SMMT is experiencing selling pressure, which indicates risk of future bearish movement.
BRK.A Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5068.2 | Buy |
Relative Strength Index (14 RSI): | 54.43 | Buy |
Chaikin Money Flow: | 23 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (683022.42 - 683056.42) | Buy |
Bollinger Bands (100): | (640347.76 - 640407.76) | Buy |
SMMT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.4 | Buy |
Relative Strength Index (14 RSI): | 69.61 | Buy |
Chaikin Money Flow: | -7453022 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (9.89 - 22.53) | Buy |
Bollinger Bands (100): | (4.23 - 14.99) | Buy |
BRK.A Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 682099.2 | Buy |
20-day SMA: | 688427.18 | Sell |
50-day SMA: | 665091.07 | Buy |
200-day SMA: | 614118.34 | Buy |
8-day EMA: | 683230.57 | Buy |
20-day EMA: | 682310.12 | Buy |
50-day EMA: | 666654.38 | Buy |
200-day EMA: | 617840.45 | Buy |
SMMT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 24.01 | Buy |
20-day SMA: | 17.36 | Buy |
50-day SMA: | 13.03 | Buy |
200-day SMA: | 6.61 | Buy |
8-day EMA: | 24.48 | Buy |
20-day EMA: | 19.28 | Buy |
50-day EMA: | 14.43 | Buy |
200-day EMA: | 8.04 | Buy |
Berkshire Hathaway Earnings Growth & BRK.A Earnings Dates
- Analysts estimate an earnings increase this quarter of $164.41 per share, an increase next quarter of $290.50 per share, an increase this year of $7,728.61 per share, and a decrease next year of $1,280.29 per share.
Summit Therapeutics Earnings Growth & SMMT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.32 per share, and a decrease next year of $0.03 per share.
Berkshire Hathaway Technical Analysis
Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Summit Therapeutics Technical Analysis
Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |